In this interview, Bruce Cozadd, Chairman and CEO of Jazz Pharmaceuticals, discusses Jazz’s 20-year legacy and what it means to create an organization that is both patient-focused and a great place to work.
In its early years, Jazz Pharmaceuticals focused its research and development efforts in areas of high unmet medical needs, which led to its foray into sleep medicine that now spans two decades. By infusing the learnings and expertise built from their expansive neuroscience portfolio, Jazz saw an opportunity to enter the oncology space, initially in hematologic cancers, and has since evolved into solid tumors.
Jazz’s ethos is defined not just by developing effective, differentiated treatments, but by considering all facets of the patient experience, from better diagnosis to the development of accurate resources and programs for patients. This includes health equity programs that aim to ensure that all patients who suffer from a disease have access to proper diagnosis and treatment.
This focus on patient commitment built a vibrant company culture that is rooted in its purpose, where employees feel this passion embodied each and every day. As a purpose-led company driven by innovation, collaboration, and enhancing patients’ lives, Jazz continues to attract and retain talent that shares this vision.
Watch the video or read the transcript to learn more about Jazz’s patient-centric approach.
